Sevoflurane in COVID-19 ARDS (SevCov)

NCT04355962 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

ARDS, Human
Coronavirus

Interventions

DRUG: Sevoflurane
DRUG: Intravenous drug

Sponsor

University of Zurich

Collaborators

[object Object]
[object Object]
[object Object]